Evidence map›Paper›PMID 25205364›Full record

ReviewClinical reviews in allergy & immunology2014

Alternaria alternata and its allergens: a comprehensive review.

Irena Kustrzeba-Wójcicka, Emilia Siwak, Grzegorz Terlecki, Anna Wolańczyk-Mędrala, Wojciech Mędrala

Abstract readReview
PubMed Publisher
In one paragraph

Review in Clinical reviews in allergy & immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 114 citations in OpenAlex.

  1. The Vacuolar CaMolecular plant pathology · 2026
    Article
  2. Review
  3. An Overview of theJournal of fungi (Basel, Switzerland) · 2026
    Review
  4. Validity of anJournal of asthma and allergy · 2026
    Article
  5. Article
  6. Article
  7. Journal of fungi (Basel, Switzerland) · 2024
    Article
  8. Article
  9. Fungal Sensitization and Human Allergic Disease.Current allergy and asthma reports · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Plants (Basel, Switzerland) · 2023
    Article
  14. Going over Fungal Allergy:Journal of fungi (Basel, Switzerland) · 2023
    Review
  15. Allergen-induced DNA release by the airway epithelium amplifies type 2 immunity.The Journal of allergy and clinical immunology · 2023
    Article
  16. New Dibenzo-Marine drugs · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Fungal Allergen and Mold Allergy Diagnosis: Role and Relevance ofJournal of fungi (Basel, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Irena Kustrzeba-WójcickaDepartment of Medical Biochemistry, Wrocław Medical University, Chałubińskiego10, 50-368, Wrocław, Poland.
Emilia Siwak
Grzegorz Terlecki
Anna Wolańczyk-Mędrala
Wojciech Mędrala
Wroclaw Medical University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alternaria alternata is mainly an outdoor fungus whose spores disseminate in warm, dry air, so in temperate climates, their count peaks in the summers. Alternaria may also be found in damp, insufficiently ventilated houses, where its allergenic properties cocreate the sick building syndrome. Mold-induced respiratory allergies and research on Alternaria both have a lengthy history: the first was described as early as 1698 and the second dates back to 1817. However, the two were only linked in 1930 when Alternaria spores were found to cause allergic asthma. The allergenic extracts from Alternaria hyphae and spores still remain in use but are variable and insufficiently standardized as they are often a random mixture of allergenic ingredients and coincidental impurities. In contrast, contemporary biochemistry and molecular biology make it possible to obtain pure allergen molecules. To date, 16 allergens of A. alternata have been isolated, many of which are enzymes: Alt a 4 (disulfide isomerase), Alt a 6 (enolase), Alt a 8 (mannitol dehydrogenase), Alt a 10 (alcohol dehydrogenase), Alt a 13 (glutathione-S-transferase), and Alt a MnSOD (Mn superoxide dismutase). Others have structural and regulatory functions: Alt a 5 and Alt a 12 comprise the structure of large ribosomal subunits and mediate translation, Alt a 3 is a molecular chaperone, Alt a 7 regulates transcription, Alt a NTF2 facilitates protein import into the nucleus, and Alt a TCTP acts like a cytokine. The function of four allergenic proteins, Alt a 1, Alt a 2, Alt a 9, and Alt a 70 kDa, remains unknown.

Indexed as

AllergensAlternariaAntigens, FungalHumansHypersensitivityTumor Protein, Translationally-Controlled 1AllergensAntigens, FungalTPT1 protein, humanTumor Protein, Translationally-Controlled 1

Identifiers

PMID25205364
OpenAlexW2056821815

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.